SeqCure Immunology AB
559094-7031ActiveDeveloping personalized, non-genetically engineered cell therapy for advanced cancer.
Overview
- 1–4
- Employees
- 1–2.5M SEK
- Revenue
- 2016
- Founded
Description
SeqCure Immunology is a Stockholm-based biotechnology startup dedicated to advancing cancer immunotherapies. The company is developing SeqCureNEO, a novel, curative, personalized cell therapy designed for treating advanced-stage cancers. This therapy is manufactured using the patient's own isolated...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559094703101
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in FunnelfeedrCuraCell Holding AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
Stallergenes Greer Sverige filial
Global biopharma leader diagnosing and treating allergies via immunotherapy.
STOCKHOLM CANCER CLUSTER
0 employeesNon-profit foundation providing infrastructure for translational cancer research.
SpectraCure AB (publ)
10–19 employeesDeveloping precise, minimally invasive PDT systems for solid tumor treatment.
Novocure Sweden AB
Global oncology company commercializing Tumor Treating Fields therapy for cancer.
Browse More
SeqCure Immunology AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo